Cerebrospinal fluid (CSF) is a clear, colorless body fluid found in the brain and spine. It is produced in the choroid plexuses of the ventricles of the brain. It acts as a cushion or buffer for the brain's cortex, providing basic mechanical and immunological protection to the brain inside the skull. The CSF also serves a vital function in cerebral autoregulation of cerebral blood flow.
The CSF occupies the subarachnoid space (between the arachnoid mater and the pia mater) and the ventricular system around and inside the brain and spinal cord. It constitutes the content of the ventricles, cisterns, and sulci of the brain, as well as the central canal of the spinal cord.
The brain produces roughly 500 mL of cerebrospinal fluid per day. This fluid is constantly reabsorbed, so that only 100-160 mL is present at any one time.
Ependymal cells of the choroid plexus produce more than two thirds of CSF. The choroid plexus is a venous plexus contained within the four ventricles of the brain, hollow structures inside the brain filled with CSF. The remainder of the CSF is produced by the surfaces of the ventricles and by the lining surrounding the subarachnoid space.
Ependymal cells actively secrete sodium into the lateral ventricles. This creates osmotic pressure and draws water into the CSF space. Chloride, with a negative charge, moves with the positively charged sodium and a neutral charge is maintained. As a result, CSF contains a higher concentration of sodium and chloride than blood plasma, but less potassium, calcium and glucose and protein.
CSF circulates within the ventricular system of the brain. The ventricles are a series of cavities filled with CSF, inside the brain. The majority of CSF is produced from within the two lateral ventricles. From here, the CSF passes through the interventricular foramina to the third ventricle, then the cerebral aqueduct to the fourth ventricle. The fourth ventricle is an outpouching on the posterior part of the brainstem. From the fourth ventricle, the fluid passes through three openings to enter the subarachnoid space – these are the median aperture, and the lateral apertures. The subarachnoid space covers the brain and spinal cord.
The CSF moves in a pulsatile manner throughout the CSF system with a nearly zero net flow, as shown on an MRI.
It had been thought that CSF returns to the vascular system by entering the dural venous sinuses via the arachnoid granulations (or villi). However, some have suggested that CSF flow along the cranial nerves and spinal nerve roots allow it into the lymphatic channels; this flow may play a substantial role in CSF reabsorbtion, in particular in the neonate, in which arachnoid granulations are sparsely distributed. The flow of CSF to the nasal submucosal lymphatic channels through the cribriform plate seems to be especially important.
The CSF contains approximately 0.3% plasma proteins, or approximately 15 to 40 mg/dL, depending on sampling site, and it is produced at a rate of 500 ml/day. Since the subarachnoid space around the brain and spinal cord can contain only 135 to 150 ml, large amounts are drained primarily into the blood through arachnoid granulations in the superior sagittal sinus. Thus the CSF turns over about 3.7 times a day. This continuous flow into the venous system dilutes the concentration of larger, lipid-insoluble molecules penetrating the brain and CSF.
|Water Content (%)||99||93|
CSF pressure, as measured by lumbar puncture (LP), is 10-18 cmH2O (8-15 mmHg or 1.1-2 kPa) with the patient lying on the side and 20-30 cmH2O (16-24 mmHg or 2.1-3.2 kPa) with the patient sitting up. In newborns, CSF pressure ranges from 8 to 10 cmH2O (4.4–7.3 mmHg or 0.78–0.98 kPa). Most variations are due to coughing or internal compression of jugular veins in the neck. When lying down, the cerebrospinal fluid as estimated by lumbar puncture is similar to the intracranial pressure.
There are quantitative differences in the distributions of a number of proteins in the CSF. In general, globular proteins and albumin are in lower concentration in ventricular CSF compared to lumbar or cisternal fluid. The IgG index of cerebrospinal fluid is a measure of the immunoglobulin G content, and is elevated in multiple sclerosis. It is defined as IgG index = (IgGCSF / IgGserum ) / (albuminCSF / albuminserum). A cutoff value has been suggested to be 0.73, with a higher value indicating presence of multiple sclerosis.
Around the third week of development, the embryo is a three-layered disc, covered on the dorsal surface by a layer of endoderm. In the middle of this surface is a linear structure called the notochord. As the endoderm proliferates, the notochord is dragged into the middle of the developing embryo and becomes the neural canal.
As the brain develops, by the fourth week of embryological development three swellings have formed within the embryo around the canal, near where the head will develop. These swellings represent different components of the central nervous system: the prosencephalon, mesencephalon and rhombencephalon.
The developing forebrain surrounds the neural cord. As the forebrain develops, the neural cord within it becomes a ventricle, ultimately forming the lateral ventricles. Along the inner surface of both ventricles, the ventricular wall remains thin, and a choroid plexus develops, releasing CSF. The CSF quickly fills the neural canal.
CSF serves several purposes:
- Buoyancy: The actual mass of the human brain is about 1400 grams; however, the net weight of the brain suspended in the CSF is equivalent to a mass of 25 grams. The brain therefore exists in neutral buoyancy, which allows the brain to maintain its density without being impaired by its own weight, which would cut off blood supply and kill neurons in the lower sections without CSF.
- Protection: CSF protects the brain tissue from injury when jolted or hit. In certain situations such as auto accidents or sports injuries, the CSF cannot protect the brain from forced contact with the skull case, causing hemorrhaging, brain damage, and sometimes death.
- Chemical stability: CSF flows throughout the inner ventricular system in the brain and is absorbed back into the bloodstream, rinsing the metabolic waste from the central nervous system through the blood–brain barrier. This allows for homeostatic regulation of the distribution of neuroendocrine factors, to which slight changes can cause problems or damage to the nervous system. For example, high glycine concentration disrupts temperature and blood pressure control, and high CSF pH causes dizziness and syncope. To use Davson's term, the CSF has a "sink action" by which the various substances formed in the nervous tissue during its metabolic activity diffuse rapidly into the CSF and are thus removed into the bloodstream as CSF is absorbed.
- Prevention of brain ischemia: The prevention of brain ischemia is made by decreasing the amount of CSF in the limited space inside the skull. This decreases total intracranial pressure and facilitates blood perfusion.
- Clearing waste: CSF has been shown by the research group of Maiken Nedergaard to be critical in the brain's glymphatic system, which plays an important role in flushing metabolic toxins or waste from the brain's tissues' cellular interstitial fluid (ISF). CSF flushing of wastes from brain tissue is further increased during sleep, which results from the opening of extracellular channels controlled through the contraction of glial cells, which allows for the rapid influx of CSF into the brain. These findings indicate that CSF may play a large role during sleep in clearing metabolic waste, like beta amyloid, that are produced by the activity in the awake brain.
When CSF pressure is elevated, cerebral blood flow may be constricted. When disorders of CSF flow occur, they may therefore affect not only CSF movement but also craniospinal compliance and the intracranial blood flow, with subsequent neuronal and glial vulnerabilities. The venous system is also important in this equation. Infants and patients shunted as small children may have particularly unexpected relationships between pressure and ventricular size, possibly due in part to venous pressure dynamics. This may have significant treatment implications, but the underlying pathophysiology needs to be further explored.
CSF connections with the lymphatic system have been demonstrated in several mammalian systems. Preliminary data suggest that these CSF-lymph connections form around the time that the CSF secretory capacity of the choroid plexus is developing (in utero). There may be some relationship between CSF disorders, including hydrocephalus and impaired CSF lymphatic transport.
CSF can leak from the dura as a result of different causes such as physical trauma or a lumbar puncture, or from no known cause when it is termed spontaneous cerebrospinal fluid leak. The leakage can cause a lack of CSF pressure and volume which can allow the brain to descend through the foramen magnum in the occipital bone where the lower portion of the brain may impact on cranial nerve complexes causing a variety of sensory symptoms.
Hydrocephalus can be caused by impaired cerebrospinal fluid (CSF) flow, reabsorption, or excessive production of CSF. Hydrocephalus is colloquially termed as "water on the brain" and is of medical importance. Hydrocephalus is an abnormal accumulation of cerebrospinal fluid (CSF) in the ventricles, or cavities, of the brain, which may cause increased intracranial pressure (ICP) inside the skull. It may lead to enlargement of the cranium if hydrocephalus occurs during development. It is usually accompanied by mental disability, sometimes by convulsive episodes and also tunnel vision. Hydrocephalus may become fatal if it is not corrected quickly. It is more common in infants, and in older adults.
Lumbar puncture is carried out under sterile conditions by inserting a needle into the subarachnoid space, usually between the third and fourth lumbar vertebrae. CSF is extracted through the needle, and tested. Cells in the fluid are counted, as are the levels of protein and glucose. These parameters alone may be extremely beneficial in the diagnosis of subarachnoid hemorrhage and central nervous system infections (such as meningitis). Moreover, a CSF culture examination may yield the microorganism that has caused the infection. By using more sophisticated methods, such as the detection of the oligoclonal bands, an ongoing inflammatory condition (for example, multiple sclerosis) can be recognized. A beta-2 transferrin assay is highly specific and sensitive for the detection of CSF leakage.
Lumbar puncture can also be performed to measure the intracranial pressure, which might be increased in certain types of hydrocephalus. However a lumbar puncture should never be performed if increased intracranial pressure is suspected due to certain situations such as a tumour, because it can lead to brain herniation and ultimately death.
About one third of people experience a headache after lumbar puncture.
This fluid has an importance in anesthesiology. Baricity refers to the density of a substance compared to the density of human cerebrospinal fluid. Baricity is used in anesthesia to determine the manner in which a particular drug will spread in the intrathecal space.
A 2010 study showed analysis of CSF for three protein biomarkers that can indicate the presence of Alzheimer's disease. The three biomarkers are CSF amyloid beta 1-42, total CSF tau protein and P-Tau181P. In the study, the biomarker test showed good sensitivity, identifying 90% of persons with Alzheimer's disease, but poor specificity, as 36% of control subjects were positive for the biomarkers. The researchers suggested the low specificity may be explained by developing but not yet symptomatic disease in controls.
Wang et al in their article show the utility of tapping CSF to identify somatic mutations causing Central Nervous System (CNS) tumors.
Various comments by ancient physicians have been read as referring to CSF. Hippocrates discussed "water" surrounding the brain when describing congenital hydrocephalus, and Galen referred to "excremental liquid" in the ventricles of the brain, which he believed was purged into the nose. But for some 16 intervening centuries of ongoing anatomical study, CSF remains unmentioned in the literature. This is perhaps because of the prevailing autopsy technique, which involved cutting off the head, thereby removing evidence of the CSF before the brain was examined. The modern rediscovery of CSF is now credited to Emanuel Swedenborg. In a manuscript written between 1741 and 1744, unpublished in his lifetime, Swedenborg referred to CSF as "spirituous lymph" secreted from the roof of the fourth ventricle down to the medulla oblongata and spinal cord. This manuscript was eventually published in translation in 1887.
Albrecht von Haller, a Swiss physician and physiologist, made note in his 1747 book on physiology that the "water" in the brain was secreted into the ventricles and absorbed in the veins, and when secreted in excess, could lead to hydrocephalus.
Francois Magendie studied the properties of CSF by vivisection. He discovered the foramen Magendie, the opening in the roof of the fourth ventricle, but mistakenly believed that CSF was secreted by the pia mater.
In 1891, W. Essex Wynter began treating tubercular meningitis by tapping the subarachnoid space, and Heinrich Quincke began to popularize lumbar puncture, which he advocated for both diagnostic and therapeutic purposes. In 19th and early 20th century literature, particularly German medical literature, liquor cerebrospinalis was a term used to refer to CSF.
In 1912, William Mestrezat gave the first accurate description of the chemical composition of the CSF. In 1914, Harvey W. Cushing published conclusive evidence that the CSF is secreted by the choroid plexus.
|Wikimedia Commons has media related to Cerebrospinal fluid.|
- Guyton, Arthur C.; Hall, John Edward (2005). Textbook of medical physiology (11th ed.). Philadelphia: W.B. Saunders. p. 764. ISBN 978-0-7216-0240-0.
- Saladin, Kenneth (2012). Anatomy and Physiology (6th ed.). McGraw Hill. pp. 519–20.
- Zakharov A, Papaiconomou C, Djenic J, Midha R, Johnston M (2003). "Lymphatic CSF absorption pathways in neonatal sheep revealed by sub arachnoid injection of Microfil". Neuropathol. Appl. Neurobiol. 29 (6): 563–73. doi:10.1046/j.0305-1846.2003.00508.x. PMID 14636163.
- Johnston M (2003). "The importance of lymphatics in cerebrospinal fluid transport". Lymphat. Res. Biol. 1 (1): 41–4. doi:10.1089/15396850360495682. PMID 15624320.
- Felgenhauer K (1974). "Protein size and CSF composition". Klin. Wochenschr. 52 (24): 1158–64. doi:10.1007/BF01466734. PMID 4456012.
- Saunders NR, Habgood MD, Dziegielewska KM (1999). "Barrier mechanisms in the brain, I. Adult brain". Clin. Exp. Pharmacol. Physiol. 26 (1): 11–9. doi:10.1046/j.1440-1681.1999.02986.x. PMID 10027064.
- Kandel. Principles of Neuroscience.
- Dimitri Agamanolis (May 2011). "Chapter 14 - Cerebrospinal Fluid :THE NORMAL CSF". Neuropathology. Northeast Ohio Medical University. Retrieved 2014-12-25.
- Merril CR, Goldman D, Sedman SA, Ebert MH (March 1981). "Ultrasensitive stain for proteins in polyacrylamide gels shows regional variation in cerebrospinal fluid proteins". Science 211 (4489): 1437–8. doi:10.1126/science.6162199. PMID 6162199.
- Hische EA, van der Helm HJ, van Walbeek HK (February 1982). "The cerebrospinal fluid immunoglobulin G index as a diagnostic aid in multiple sclerosis: a Bayesian approach". Clinical Chemistry 28 (2): 354–5. PMID 7055958.
- PATHOLOGY 425 CEREBROSPINAL FLUID [CSF] at the Department of Pathology and Laboratory Medicine at the University of British Columbia. By Dr. G.P. Bondy. Retrieved November 2011[dead link]
- Normal Reference Range Table from The University of Texas Southwestern Medical Center at Dallas. Used in Interactive Case Study Companion to Pathologic basis of disease. Archived August 10, 2015 at the Wayback Machine
- Department of Chemical Pathology at the Chinese University of Hong Kong, in turn citing: Roberts WL et al. Reference Information for the Clinical Laboratory. In Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 4th edn. Burtis CA, Ashwood ER and Bruns DE eds. Elsevier Saunders 2006; 2251 - 2318
- Lab Manual for SFGH > PROTEIN, CSF - IgG INDEX at The University of California, San Francisco. Last updated 10/4/2010.
- Standardization of procedures and methods in neuroimmunology[page needed] from the Italian Association of Neuroimmunology. Retrieved January, 2012
- Derived from mmHg values using 0.133322 kPa/mmHg
- Schoenwolf, Gary C.; Larsen, William James (2009). "Development of the Brain and Cranial Nerves". Larsen's human embryology (4th ed.). Philadelphia: Churchill Livingstone/Elsevier. ISBN 978-0-443-06811-9.[page needed]
- Noback, Charles; Norman L. Strominger; Robert J. Demarest; David A. Ruggiero (2005). The Human Nervous System. Humana Press. p. 93. ISBN 978-1-58829-040-3.
- Saladin, Kenneth (2007). Anatomy and Physiology: The Unity of Form and Function. McGraw Hill. p. 520. ISBN 978-0-07-287506-5.,
- Allan H. Ropper, Robert H. Brown Adams and Victor's Principles of Neurology McGraw-Hill Professional; 8 edition (March 29, 2005) Ch. 30 p. 530.
- Iliff JJ, Wang M, Liao Y; et al. (August 2012). "A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β". Science Translational Medicine 4 (147): 147ra111. doi:10.1126/scitranslmed.3003748. PMC 3551275. PMID 22896675.
- Xie L, Kang H, Xu Q; et al. (October 2013). "Sleep drives metabolite clearance from the adult brain". Science 342 (6156): 373–7. doi:10.1126/science.1241224. PMID 24136970.
- "Hydrocephalus: Myths, New Facts, Clear Directions". National Institute of Neurological Disorders and Stroke. NIH. 2011-03-10. Retrieved 2015-01-05.
- "Hydrocephalus Fact Sheet", National Institute of Neurological Disorders and Stroke. (August 2005).
- Seehusen DA, Reeves MM, Fomin DA (September 2003). "CSF analysis". Am Fam Physician 68 (6): 1103–8. PMID 14524396.
- Colledge, Nicki R.; Walker, Brian R.; Ralston, Stuart H., eds. (2010). Davidson's principles and practice of medicine (21st ed.). Edinburgh: Churchill Livingstone/Elsevier. pp. 1147–8. ISBN 978-0-7020-3084-0.
- De Meyer G, Shapiro F, Vanderstichele H; et al. (August 2010). "Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people". Archives of Neurology 67 (8): 949–56. doi:10.1001/archneurol.2010.179. PMC 2963067. PMID 20697045.
- Herskovits AZ, Growdon JH (August 2010). "Sharpen that needle". Archives of Neurology 67 (8): 918–20. doi:10.1001/archneurol.2010.151. PMID 20697041.
- Hajdu SI (2003). "A note from history: discovery of the cerebrospinal fluid". Annals of Clinical and Laboratory Science 33 (3): 334–6. PMID 12956452.
- Circulation of Cerebrospinal Fluid (CSF) - Interactive Tool
- Cerebrospinal fluid - course material in neuropathology
- Identification of the Cerebrospinal Fluid System Dynamics